Q0512 HCPCS code: Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period

Q0512 is the HCPCS Level II code for pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period. In 2024 Medicare paid an average of $11.98 per service for Q0512 across 1,220,420 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 4 per day on DME suppliers. Medicare volume fell 9% from 2022 to 2024 (1,347,655 to 1,220,420 services). In 2024, 19,690 suppliers billed Medicare for Q0512 (purchases), serving 105,931 beneficiaries; California, New York, Florida accounted for 27% of services.

Code details

FieldValue
SectionQ codes — Temporary codes
Coverage codeD — Special coverage instructions apply
Pricing indicator46 — Priced by the Medicare contractor (no national fee)
BETOS categoryO1E — Other drugs
Added2006-01-01
Last action effective2009-01-01

Who bills Q0512 (2024)

MeasureValue
Suppliers billing rentals—
Suppliers billing purchases19,690
Referring clinicians27,847
Medicare beneficiaries105,931
States with claims53
Share of services in top 3 states (California, New York, Florida)27%
YearSuppliersBeneficiaries
202221,439114,424
202320,951110,958
202419,690105,931

Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.

Medicare utilization for Q0512, 2022–2024

YearServicesBeneficiariesAvg. allowedAvg. paid
20221,347,655114,424$16.00$12.21
20231,308,274110,958$16.00$12.05
20241,220,420105,931$16.00$11.98

States with the most Q0512 services (2024)

StateServicesAvg. paid
California149,080$11.94
New York96,041$12.06
Florida83,604$12.03
Texas78,664$11.96
Pennsylvania51,743$11.94

NCCI unit limits (MUE)

Claim typeMax units per dayRationale
DME suppliers4Clinical: Data
outpatient hospital claims4Clinical: Data

Medicare policy articles for this code

Covered diagnoses (1,551 ICD-10-CM codes)

The diagnoses most often listed as covered in the policy articles above:

ICD-10-CMDiagnosisArticles listing it
C00.0Malignant neoplasm of external upper lip2
C00.1Malignant neoplasm of external lower lip2
C00.3Malignant neoplasm of upper lip, inner aspect2
C00.4Malignant neoplasm of lower lip, inner aspect2
C00.6Malignant neoplasm of commissure of lip, unspecified2
C00.8Malignant neoplasm of overlapping sites of lip2
C01Malignant neoplasm of base of tongue2
C02.0Malignant neoplasm of dorsal surface of tongue2
C02.1Malignant neoplasm of border of tongue2
C02.2Malignant neoplasm of ventral surface of tongue2

Showing 10 of 1,551. The full list, non-covered diagnoses and CSV export are in Caduvo.

What changed for Q0512

Frequently asked questions

What is HCPCS code Q0512?

Q0512 is the HCPCS Level II code for pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period. Short descriptor: "Px sup fee anti-can sub pres".

How much does Medicare pay for Q0512?

In 2024, the average Medicare payment was $11.98 per service (average allowed $16.00).

Does Medicare cover Q0512?

Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.

Which diagnoses support coverage for Q0512?

Medicare policy articles that cite Q0512 list 1,551 covered ICD-10-CM diagnosis codes across 3 articles. The most cited include C00.0 (Malignant neoplasm of external upper lip), C00.1 (Malignant neoplasm of external lower lip), C00.3 (Malignant neoplasm of upper lip, inner aspect). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.

How many units of Q0512 can be billed per day?

4 on DME suppliers; 4 on outpatient hospital claims (NCCI medically unlikely edits).

Related Q05 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.

All Q codes · HCPCS lookup